NCT06629909
Safety and Feasibility of Human Umbilical Cord Mesenchymal Stem Cell-Derived Secretome in the Treatment of Liver Cirrhosis: a Comprehensive Evaluation of Fibrosis Reduction, Immunomodulation, and Hepatic Regeneration: a Single Center, Randomized, Phase I Clinical Trial
Phase: Phase 1
Role: Lead Sponsor
Start: Dec 1, 2024
Completion: Oct 31, 2026